Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Strides Pharma Science Ltd.

NSE: STAR | BSE: 532531 | ISIN: INE939A01011 | Industry: Pharmaceuticals
| Strong Performer, Under Radar

651.3500 12.90 (2.02%)

NSE May 12, 2025 15:31 PM

61.11% Fall from 52W High

Volume: 358.6K

Strides Pharma Science Ltd.

14 Sep 2023

651.35

2.02%

Company Update

Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Strides receives tentative USFDA approval for Dolutegravir tablets

More from Strides Pharma Science Ltd.

Recommended

Which stocks did superstar investors buy in Q4FY25?

The Baseline | 12 May 2025, 04:25PM

Market closes higher, Triveni Turbine's Q4 net profit grows 23.6% YoY to Rs 93.9 crore

Trendlyne Marketwatch | 12 May 2025, 04:03PM

Earnings Call Transcript - Q1FY21 for Strides Pharma Science